Correction to: iHIVARNA phase IIa, a randomized, placebo-controlled, double-blinded trial to evaluate the safety and immunogenicity of iHIVARNA-01 in chronically HIV-infected patients under stable combined antiretroviral therapy

iHIVARNA Consortium

Research output: Contribution to journalLetter

Abstract

Following publication of the original article [1], we have been notified that end note would need to be adjusted.

Original languageEnglish
JournalTrials
Volume20
Issue number1
Pages (from-to)721
ISSN1745-6215
DOIs
Publication statusPublished - 2019

Fingerprint Dive into the research topics of 'Correction to: iHIVARNA phase IIa, a randomized, placebo-controlled, double-blinded trial to evaluate the safety and immunogenicity of iHIVARNA-01 in chronically HIV-infected patients under stable combined antiretroviral therapy'. Together they form a unique fingerprint.

Cite this